These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7842825)

  • 21. A pharmacokinetic/pharmacodynamic approach to show that not all fluoroquinolones exhibit similar sensitivity toward the proconvulsant effect of biphenyl acetic acid in rats.
    Marchand S; Pariat C; Boulanger A; Bouquet S; Couet W
    J Antimicrob Chemother; 2001 Dec; 48(6):813-20. PubMed ID: 11733465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that a hybrid molecule of norfloxacin and biphenylacetic acid is a potent antagonist at the GABAA receptor.
    Imanishi T; Akahane K; Akaike N
    Neuropharmacology; 1996; 35(9-10):1271-7. PubMed ID: 9014142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib does not induce convulsions nor does it affect GABAA receptor binding activity in the presence of new quinolones in mice.
    Yoshino T; Noguchi M; Okutsu H; Kimoto A; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):69-76. PubMed ID: 15659296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
    Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
    Segev S; Rehavi M; Rubinstein E
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1624-6. PubMed ID: 2855295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid.
    Green MA; Halliwell RF
    Br J Pharmacol; 1997 Oct; 122(3):584-90. PubMed ID: 9351519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci.
    Foleno BD; Lafredo SC; Fu KP
    Chemotherapy; 1993; 39(2):120-3. PubMed ID: 8458244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphenylacetic acid enhances the antagonistic action of fluoroquinolones on the GABA(A)-mediated responses of the isolated guinea-pig ileum.
    Koutsoviti-Papadopoulou M; Nikolaidis E; Kounenis G
    Pharmacol Res; 2001 Sep; 44(3):229-33. PubMed ID: 11529690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.
    García I; Pascual A; Ballesta S; Perea EJ
    Int J Antimicrob Agents; 2000 Aug; 15(3):201-5. PubMed ID: 10926442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in brain interleukin-1beta following the coadministration of norfloxacin with biphenylacetic acid in rats.
    Zhang LR; Li XT; Tang WL; Wang YM; Cheng NN; Chen BY
    Eur J Pharmacol; 2006 Aug; 543(1-3):21-6. PubMed ID: 16824509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC; Foleno BD; Fu KP
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of various non-steroidal anti-inflammatories and quinolone antimicrobials on GABA response in rat dissociated hippocampal pyramidal neurons.
    Shirasaki T; Harata N; Nakaye T; Akaike N
    Brain Res; 1991 Oct; 562(2):329-31. PubMed ID: 1663416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convulsant activity of sitafloxacin and its interactions with anti-inflammatory drugs in mice.
    Hori S
    J Infect Chemother; 2009 Aug; 15(4):266-8. PubMed ID: 19688249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats.
    Ichikawa N; Naora K; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Nov; 44(11):915-20. PubMed ID: 1361537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Central stimulating effect of the combination of the new quinolone group of antimicrobials and nonsteroidal anti-inflammatory drugs in mice].
    Murayama S; Hara Y; Ally A; Suzuki T; Tamagawa M
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):13-8. PubMed ID: 1313777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
    Fujimoto T; Mitsuhashi S
    Chemotherapy; 1990; 36(4):268-76. PubMed ID: 2174762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
    Yamakuchi M; Nakata M; Kawahara K; Kitajima I; Maruyama I
    Cancer Lett; 1997 Nov; 119(2):213-9. PubMed ID: 9570374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse drug interactions between pyridonecarboxylic acids and nonsteroidal antiinflammatory drugs: convulsion after oral or intracerebral administration in mice].
    Hirai S; Tanaka K; Makino S; Narita H
    Yakugaku Zasshi; 1989 Feb; 109(2):119-26. PubMed ID: 2746470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.